1. Home
  2. RVMD vs ACGL Comparison

RVMD vs ACGL Comparison

Compare RVMD & ACGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$187.35

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Arch Capital Group Ltd.

ACGL

Arch Capital Group Ltd.

HOLD

Current Price

$101.07

Market Cap

31.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
ACGL
Founded
2014
2001
Country
United States
Bermuda
Employees
883
8000
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
31.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RVMD
ACGL
Price
$187.35
$101.07
Analyst Decision
Strong Buy
Buy
Analyst Count
19
15
Target Price
$140.84
$108.50
AVG Volume (30 Days)
2.8M
1.9M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$533.02
$3.34
P/E Ratio
N/A
$8.45
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$82.45
52 Week High
$193.83
$105.09

Technical Indicators

Market Signals
Indicator
RVMD
ACGL
Relative Strength Index (RSI) 66.86 65.20
Support Level $93.39 $91.44
Resistance Level N/A $102.40
Average True Range (ATR) 7.33 2.07
MACD 0.42 0.66
Stochastic Oscillator 79.87 69.72

Price Performance

Historical Comparison
RVMD
ACGL

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About ACGL Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

Share on Social Networks: